In the last trading session, 1.25 million shares of the Achieve Life Sciences Inc (NASDAQ:ACHV) were traded, and its beta was 1.30. Most recently the company’s share price was $2.26, and it changed around $0.19 or 9.18% from the last close, which brings the market valuation of the company to $112.29M. ACHV currently trades at a discount to its 52-week high of $5.31, offering almost -134.96% off that amount. The share price’s 52-week low was $1.84, which indicates that the current value has risen by an impressive 18.58% since then. We note from Achieve Life Sciences Inc’s average daily trading volume that its 10-day average is 2.33 million shares, with the 3-month average coming to 585.17K.
Achieve Life Sciences Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 6 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended ACHV as a Hold, whereas 5 deemed it a Buy, and 0 rated it as Underweight.
Achieve Life Sciences Inc (NASDAQ:ACHV) trade information
Instantly ACHV has showed a green trend with a performance of 9.18% at the end of last trading. The rise to weekly highs of 2.31 on recent trading dayincreased the stock’s daily price by 2.16%. On the other hand, Achieve Life Sciences Inc (NASDAQ:ACHV) is -35.89% down in the 30-day period. We can see from the shorts that 2.97 million shares have been sold at a short interest cover period of 9.04 day(s).
The consensus price target as assigned by Wall Street analysts is $4.75, which translates to bulls needing to increase their stock price by 52.42% from its current value. Analyst projections state that ACHV is forecast to be at a low of $4 and a high of $5.5.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 50.01%.
ACHV Dividends
Achieve Life Sciences Inc’s next quarterly earnings report is expected to be released on 2025-May-13.
Achieve Life Sciences Inc (NASDAQ:ACHV)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 9.69% of Achieve Life Sciences Inc shares, and 41.59% of them are in the hands of institutional investors. The stock currently has a share float of 46.05%. Achieve Life Sciences Inc stock is held by 99.0 institutions, with FRANKLIN RESOURCES INC being the largest institutional investor. By 2024-06-30, it held 17.6358% of the shares, which is about 6.05 million shares worth $19.6 million.
PROPEL BIO MANAGEMENT, LLC, with 7.148% or 2.45 million shares worth $11.53 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
